A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy
Clinical Trial Grant
Awarded By
Eidos Therapeutics
Start Date
October 27, 2025
End Date
October 31, 2031
Awarded By
Eidos Therapeutics
Start Date
October 27, 2025
End Date
October 31, 2031